S&P 500   3,979.71 (+0.22%)
DOW   32,465.01 (+0.71%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,979.71 (+0.22%)
DOW   32,465.01 (+0.71%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,979.71 (+0.22%)
DOW   32,465.01 (+0.71%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,979.71 (+0.22%)
DOW   32,465.01 (+0.71%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
NASDAQ:CHNA

Loncar China BioPharma ETF - CHNA Price, Holdings, & News

$18.12
-0.13 (-0.71%)
(As of 03/27/2023 12:21 PM ET)
Add
Compare
Today's Range
$18.12
▼
$18.12
50-Day Range
$17.72
▼
$22.53
52-Week Range
$13.35
▼
$22.89
Volume
261 shs
Average Volume
861 shs
Market Capitalization
$5.44 million
Assets Under Management
$10.00 million
Dividend Yield
16.72%
Net Expense Ratio
0.79%
CHNA stock logo

About Loncar China BioPharma ETF (NASDAQ:CHNA)

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China BioPharma ETF and its competitors with MarketBeat's FREE daily newsletter.

CHNA ETF News Headlines

March 24, 2023 | morningstar.com
Loncar China BioPharma ETF
March 19, 2023 | benzinga.com
J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active China ETF (ARCA:JCHI), Dividends
March 27, 2023 | UNKNOWN (Ad)
This Mining Stock Has The Keys To Our Future!
The Stock Market Is Changing And This Company Is At The Forefront Of The Next Rally!pixel
March 19, 2023 | americanbankingnews.com
Loncar China BioPharma ETF (NASDAQ:CHNA) Shares Down 3.2%
March 6, 2023 | theglobeandmail.com
Closing Bell: CI Icbccs SP China 500 Index ETF NH up on Friday (CHNA-B)
March 1, 2023 | thestreet.com
China ETFs Best Way to Play Alibaba IPO, E-Commerce Boom
February 18, 2023 | theglobeandmail.com
Closing Bell: CI Icbccs SP China 500 Index ETF NH flat on Thursday (CHNA-B)
January 23, 2023 | msn.com
What Lies Ahead for China ETFs in the Year of Rabbit?
March 27, 2023 | UNKNOWN (Ad)
This Mining Stock Has The Keys To Our Future!
The Stock Market Is Changing And This Company Is At The Forefront Of The Next Rally!pixel
January 13, 2023 | finance.yahoo.com
China ETFs Led the Way in Last Week’s Top-Performing ETFs
See More Headlines
Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China BioPharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Loncar China Biopharma ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CHNA
Inception Date
8/14/2018
Fund Manager
Denise M. Krisko, Habib Moudachirou
Web
N/A
Phone
14089961010

Fund Focus

Asset Class
Equity
Benchmark
Loncar China BioPharma Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
0

Fund Statistics

Assets Under Management
$10.00 million
Average Daily Volume
$7,640.20
Discount/Premium
0.13%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank National Association
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Outstanding Shares
300,000
Beta
0.68

Loncar China BioPharma ETF Expenses

TypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.56%0.51%0.45%0.49%
Other Expenses0.00%0.37%0.52%0.34%0.55%
Total Expense0.79%0.71%0.68%0.55%0.68%
Fee Waiver0.00%-0.41%-0.54%-0.33%-0.58%
Net Expense0.79%0.61%0.58%0.49%0.56%

Loncar China BioPharma ETF (CHNA) Holdings & Exposure

Top 10 CHNA Holdings

  • CSPC Pharmaceutical Group Ltd
    Holding Weight: 2.27%
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
    Holding Weight: 2.22%
  • BeiGene(NASDAQ:BGNE)
    Holding Weight: 2.20%
  • Hansoh Pharmaceutical Group Co Ltd
    Holding Weight: 2.17%
  • Sino Biopharmaceutical Ltd
    Holding Weight: 2.13%
  • Wuxi AppTec Co Ltd
    Holding Weight: 2.11%
  • WuXi Biologics (Cayman) Inc
    Holding Weight: 2.07%
  • Hangzhou Tigermed Consulting Co Ltd Class H
    Holding Weight: 2.05%
  • Pharmaron Beijing Co Ltd Ordinary Shares - Class H
    Holding Weight: 1.94%
  • Sinopharm Group Co Ltd
    Holding Weight: 1.85%

CHNA Sector Exposure

CHNA Industry Exposure

Full Holdings Details













CHNA ETF - Frequently Asked Questions

How have CHNA shares performed in 2023?

Loncar China BioPharma ETF's stock was trading at $18.77 at the beginning of 2023. Since then, CHNA shares have decreased by 5.6% and is now trading at $17.72.
View the best growth stocks for 2023 here.

What does CHNA invest in?

Loncar China BioPharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $10.00 million assets under management.

What stocks does Loncar China BioPharma ETF hold?

CHNA invests in 0 holdings. Some of the stocks in their portfolio include BeiGene (BGNE), Zai Lab (ZLAB), Legend Biotech (LEGN), HUTCHMED (HCM), Burning Rock Biotech (BNR), I-Mab (IMAB) and LianBio (LIAN).

What is the management fee for Loncar China BioPharma ETF?

Loncar China BioPharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%.

What other stocks do shareholders of Loncar China BioPharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China BioPharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI).

What is Loncar China BioPharma ETF's stock symbol?

Loncar China BioPharma ETF trades on the NASDAQ under the ticker symbol "CHNA."

Who are Loncar China BioPharma ETF's major shareholders?

Loncar China BioPharma ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include OLD Mission Capital LLC (1.54%).

How do I buy shares of Loncar China BioPharma ETF?

Shares of CHNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Loncar China BioPharma ETF's stock price today?

One share of CHNA stock can currently be purchased for approximately $17.72.

How much money does Loncar China BioPharma ETF make?

Loncar China BioPharma ETF (NASDAQ:CHNA) has a market capitalization of $5.32 million.

How many employees does Loncar China BioPharma ETF have?

The company employs 147,000 workers across the globe.

How can I contact Loncar China BioPharma ETF?

The company can be reached via phone at 14089961010.

This page (NASDAQ:CHNA) was last updated on 3/27/2023 by MarketBeat.com Staff